Biomedical company conceived in London and founded in Italy

IBD is an innovative SME, a manufacturer of biomedical devices conceived in London and founded in Italy in 2014.

Led by a team with more than 10 years of experience in medical device design, IBD has so far raised over € 1 million in business angel funding and grants.

It is now facing a new round of funding and is constantly looking for investors who believe in the values ​​and goals that drive IBD.

Our
Vision

IBD considers the Reverse Innovation of medical devices the key to making quality health care accessible to the whole world .

Our
Mission

Our mission is tackling health problems through the application of the principles of reverse innovation.

We observe the technological limitations and clinical needs existing in the global healthcare environment to create the best solution in terms of safety and efficacy , optimization of costs, and usability .

Our story

2014

Development Activities

The MyDial technological concept has been formulated.

Foundation

In May 2014 Corrado Ghidini and Andrea Visotti founded the Start up IBD Srl and opened an R&D laboratory in Bologna (Italy).


Development Activities

The first prototype of MyDial was developed using a PC-controlled data acquisition platform.

2015


2016

EN ISO 13485 and EN ISO 9001 certifications

IBD obtained the EN ISO 13485 and EN ISO 9001 Certifications from TUV Sud

Development Activities

The second prototype of MyDial, based on a first version of PC-independent embedded electronics, was developed and tested in the laboratory.


Development Activities

IBD prototyped the Manifold, improved the ultrafiltration control and started activities to obtain the CE certification of Dial-IT

2017


2018

Seal of Excellence Horizon 2020

Certificate 854722 delivered by the European Commission, as the institution managing Horizon 2020, the EU Framework Programme for Research and Innovation 2014-2020.

POR FESR call for innovative Startups

IBD obtained non-repayable loan of 100k€ from the Emilia-Romagna Region.

Third Prototype Tested and Validated

The third protype of MyDial has been tested and validated in vitro.


Industrialization and Certification process

Industrialization and Certification process Industrialization of the whole MyDial system and CE certification process begins, for hospital use.

Seals of Excellence Horizon 2020

Seals of Excellence Horizon 2020 Two more seals assigned by European Commission: 867214 – 888419

2019


2020

Horizon 2020 seals of excellence

Certificate issued by the European Commission, as managing body of Horizon 2020, of the EU Framework Program for Research and Innovation 2014-2020 for proposal 970477.

With the outbreak of the Covid-19 pandemic, Biorespira was born

To respond to the pandemic, engineers create the first prototype of the Biorespira lung ventilator in just 5 weeks.

Partnership with SECO Group for the industrialization of Biorespira

Partnership with SECO GROUP, a leading company in the hi-tech sector, specialized in IT miniaturization, supported by FII Tech Growth managed by the Italian Investment Fund SGR, for the industrialization of Biorespira.

Crowdfunding campaign #LETTHEMBREATHE

IBD has launched a successful crowdfunding campaign, called #LetThemBreathe, to support Biorespira’s development activities.

Development of BioRespira

During the COVID-19 pandemic, in an effort to help alleviate the emergency and shocked by the scarce presence of ventilator manufacturers in Italy, the team decided to develop a sub-intensive care ventilator with high flow and mixing of oxygen.

CE Biorespira certification

Biorespira has been tested and validated and CE certified by KIWA Cermet Italia.

Our Story

2014

Development Activities

The MyDial technological concept has been formulated.

Foundation

In May 2014 Corrado Ghidini and Andrea Visotti founded the Start up IBD Srl and opened an R&D laboratory in Bologna (Italy).


Development Activities

The first prototype of MyDial was developed using a PC-controlled data acquisition platform.

2015


2016

EN ISO 13485 and EN ISO 9001 certifications

IBD obtained the EN ISO 13485 and EN ISO 9001 Certifications from TUV Sud

Development Activities

The second prototype of MyDial, based on a first version of PC-independent embedded electronics, was developed and tested in the laboratory.


Development Activities

IBD prototyped the Manifold, improved the ultrafiltration control and started activities to obtain the CE certification of Dial-IT

2017


2018

Seal of Excellence Horizon 2020

Certificate 854722 delivered by the European Commission, as the institution managing Horizon 2020, the EU Framework Programme for Research and Innovation 2014-2020.

POR FESR call for innovative Startups

IBD obtained non-repayable loan of 100k€ from the Emilia-Romagna Region.

Third Prototype Tested and Validated

The third protype of MyDial has been tested and validated in vitro.


Industrialization and Certification process

Industrialization and Certification process Industrialization of the whole MyDial system and CE certification process begins, for hospital use.

Seals of Excellence Horizon 2020

Seals of Excellence Horizon 2020 Two more seals assigned by European Commission: 867214 – 888419

2019


2020

Horizon 2020 seals of excellence

Certificate issued by the European Commission, as managing body of Horizon 2020, of the EU Framework Program for Research and Innovation 2014-2020 for proposal 970477.

With the outbreak of the Covid-19 pandemic, Biorespira was born

To respond to the pandemic, engineers create the first prototype of the Biorespira lung ventilator in just 5 weeks.

Partnership with SECO Group for the industrialization of Biorespira

Partnership with SECO GROUP, a leading company in the hi-tech sector, specialized in IT miniaturization, supported by FII Tech Growth managed by the Italian Investment Fund SGR, for the industrialization of Biorespira.

Crowdfunding campaign #LETTHEMBREATHE

IBD has launched a successful crowdfunding campaign, called #LetThemBreathe, to support Biorespira’s development activities.

Development of BioRespira

During the COVID-19 pandemic, in an effort to help alleviate the emergency and shocked by the scarce presence of ventilator manufacturers in Italy, the team decided to develop a sub-intensive care ventilator with high flow and mixing of oxygen.

CE Biorespira certification

Biorespira has been tested and validated and CE certified by KIWA Cermet Italia.

Our Story

2014

Development Activities

The MyDial technological concept has been formulated.

Foundation

In May 2014 Corrado Ghidini and Andrea Visotti founded the Start up IBD Srl and opened an R&D laboratory in Bologna (Italy).


Development Activities

The first prototype of MyDial was developed using a PC-controlled data acquisition platform.

2015


2016

EN ISO 13485 and EN ISO 9001 certifications

IBD obtained the EN ISO 13485 and EN ISO 9001 Certifications from TUV Sud

Development Activities

The second prototype of MyDial, based on a first version of PC-independent embedded electronics, was developed and tested in the laboratory.


Development Activities

IBD prototyped the Manifold, improved the ultrafiltration control and started activities to obtain the CE certification of Dial-IT

2017


2018

Seal of Excellence Horizon 2020

Certificate 854722 delivered by the European Commission, as the institution managing Horizon 2020, the EU Framework Programme for Research and Innovation 2014-2020.

POR FESR call for innovative Startups

IBD obtained non-repayable loan of 100k€ from the Emilia-Romagna Region.

Third Prototype Tested and Validated

The third protype of MyDial has been tested and validated in vitro.


Industrialization and Certification process

Industrialization and Certification process Industrialization of the whole MyDial system and CE certification process begins, for hospital use.

Seals of Excellence Horizon 2020

Seals of Excellence Horizon 2020 Two more seals assigned by European Commission: 867214 – 888419

2019


2020

Horizon 2020 seals of excellence

Certificate issued by the European Commission, as managing body of Horizon 2020, of the EU Framework Program for Research and Innovation 2014-2020 for proposal 970477.

With the outbreak of the Covid-19 pandemic, Biorespira was born

To respond to the pandemic, engineers create the first prototype of the Biorespira lung ventilator in just 5 weeks.

Partnership with SECO Group for the industrialization of Biorespira

Partnership with SECO GROUP, a leading company in the hi-tech sector, specialized in IT miniaturization, supported by FII Tech Growth managed by the Italian Investment Fund SGR, for the industrialization of Biorespira.

Crowdfunding campaign #LETTHEMBREATHE

IBD has launched a successful crowdfunding campaign, called #LetThemBreathe, to support Biorespira’s development activities.

Development of BioRespira

During the COVID-19 pandemic, in an effort to help alleviate the emergency and shocked by the scarce presence of ventilator manufacturers in Italy, the team decided to develop a sub-intensive care ventilator with high flow and mixing of oxygen.

CE Biorespira certification

Biorespira has been tested and validated and CE certified by KIWA Cermet Italia.



In compliance with the Italian Ministry of Health’s provisions regarding health advertising relating to medical devices, in vitro diagnostic medical devices and medical-surgical devices, IBD informs that the contents of this site are intended exclusively for healthcare professionals. The description of the products is for information purposes only and is not intended to promote them.

IBD ITALIAN BIOMEDICAL DEVICES SRL
Via Tasso 14 – 46043 Castiglione delle Stiviere Mantova – Italia | P.IVA 02433320203

Privacy Policy and Cookies

Follow Us

© IBD biomed All rights reserved.